Annual Debt To Equity:
1.57-3.02(-65.80%)Summary
- As of today, ARWR annual debt to equity ratio is 1.57, with the most recent change of -3.02 (-65.80%) on September 30, 2025.
- During the last 3 years, ARWR annual debt to equity has risen by +1.37 (+685.00%).
- ARWR annual debt to equity is now -65.80% below its all-time high of 4.59, reached on September 30, 2024.
Performance
ARWR Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Debt To Equity:
1.57+0.20(+14.60%)Summary
- As of today, ARWR quarterly debt to equity ratio is 1.57, with the most recent change of +0.20 (+14.60%) on September 1, 2025.
- Over the past year, ARWR quarterly debt to equity has dropped by -3.02 (-65.80%).
- ARWR quarterly debt to equity is now -90.53% below its all-time high of 16.58, reached on December 31, 2024.
Performance
ARWR Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
ARWR Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -65.8% | -65.8% |
| 3Y3 Years | +685.0% | +685.0% |
| 5Y5 Years | +3040.0% | +3040.0% |
ARWR Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -65.8% | +685.0% | -90.5% | +726.3% |
| 5Y | 5-Year | -65.8% | +3040.0% | -90.5% | +3040.0% |
| All-Time | All-Time | -65.8% | +375.4% | -90.5% | +361.7% |
ARWR Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | 1.57(-65.8%) | - |
| Sep 2025 | - | 1.57(+14.6%) |
| Jun 2025 | - | 1.37(+26.9%) |
| Mar 2025 | - | 1.08(-93.5%) |
| Dec 2024 | - | 16.58(+261.2%) |
| Sep 2024 | 4.59(+225.5%) | 4.59(+235.0%) |
| Jun 2024 | - | 1.37(+65.1%) |
| Mar 2024 | - | 0.83(-66.1%) |
| Dec 2023 | - | 2.45(+73.8%) |
| Sep 2023 | 1.41(+605.0%) | 1.41(+513.0%) |
| Jun 2023 | - | 0.23(+21.1%) |
| Mar 2023 | - | 0.19(-13.6%) |
| Dec 2022 | - | 0.22(+10.0%) |
| Sep 2022 | 0.20(+233.3%) | 0.20(+11.1%) |
| Jun 2022 | - | 0.18(+200.0%) |
| Mar 2022 | - | 0.06(-14.3%) |
| Dec 2021 | - | 0.07(+16.7%) |
| Sep 2021 | 0.06(+20.0%) | 0.06(0.0%) |
| Jun 2021 | - | 0.06(+20.0%) |
| Mar 2021 | - | 0.05(0.0%) |
| Dec 2020 | - | 0.05(0.0%) |
| Sep 2020 | 0.05(>+9900.0%) | 0.05(+25.0%) |
| Jun 2020 | - | 0.04(+33.3%) |
| Mar 2020 | - | 0.03(0.0%) |
| Dec 2019 | - | 0.03(>+9900.0%) |
| Sep 2019 | 0.00(-100.0%) | 0.00(0.0%) |
| Jun 2019 | - | 0.00(0.0%) |
| Mar 2019 | - | 0.00(0.0%) |
| Dec 2018 | - | 0.00(-100.0%) |
| Sep 2018 | 0.02(-33.3%) | 0.02(0.0%) |
| Jun 2018 | - | 0.02(0.0%) |
| Mar 2018 | - | 0.02(-50.0%) |
| Dec 2017 | - | 0.04(+33.3%) |
| Sep 2017 | 0.03(0.0%) | 0.03(0.0%) |
| Jun 2017 | - | 0.03(0.0%) |
| Mar 2017 | - | 0.03(0.0%) |
| Dec 2016 | - | 0.03(0.0%) |
| Sep 2016 | 0.03(+200.0%) | 0.03(-50.0%) |
| Jun 2016 | - | 0.06(+500.0%) |
| Mar 2016 | - | 0.01(0.0%) |
| Dec 2015 | - | 0.01(0.0%) |
| Sep 2015 | 0.01(0.0%) | 0.01(0.0%) |
| Jun 2015 | - | 0.01(0.0%) |
| Mar 2015 | - | 0.01(0.0%) |
| Dec 2014 | - | 0.01(0.0%) |
| Sep 2014 | 0.01(-87.5%) | 0.01(0.0%) |
| Jun 2014 | - | 0.01(0.0%) |
| Mar 2014 | - | 0.01(-66.7%) |
| Dec 2013 | - | 0.03(-62.5%) |
| Sep 2013 | 0.08(-61.9%) | 0.08(+14.3%) |
| Jun 2013 | - | 0.07(-84.1%) |
| Mar 2013 | - | 0.44(+91.3%) |
| Dec 2012 | - | 0.23(+9.5%) |
| Sep 2012 | 0.21 | 0.21(-8.7%) |
| Jun 2012 | - | 0.23(+43.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | 0.16(+33.3%) |
| Dec 2011 | - | 0.12(+200.0%) |
| Sep 2011 | 0.04(-33.3%) | 0.04(-20.0%) |
| Jun 2011 | - | 0.05(+25.0%) |
| Mar 2011 | - | 0.04(-33.3%) |
| Dec 2010 | - | 0.06(0.0%) |
| Sep 2010 | 0.06(-76.0%) | 0.06(0.0%) |
| Jun 2010 | - | 0.06(-57.1%) |
| Mar 2010 | - | 0.14(-12.5%) |
| Dec 2009 | - | 0.16(-36.0%) |
| Sep 2009 | 0.25(+108.3%) | 0.25(-26.5%) |
| Jun 2009 | - | 0.34(-77.6%) |
| Mar 2009 | - | 1.52(+176.4%) |
| Dec 2008 | - | 0.55(+358.3%) |
| Sep 2008 | 0.12(>+9900.0%) | 0.12(>+9900.0%) |
| Jun 2008 | - | 0.00(0.0%) |
| Mar 2008 | - | 0.00(0.0%) |
| Dec 2007 | - | 0.00(0.0%) |
| Sep 2007 | 0.00(0.0%) | 0.00(0.0%) |
| Jun 2007 | - | 0.00(0.0%) |
| Mar 2007 | - | 0.00(0.0%) |
| Dec 2006 | - | 0.00(0.0%) |
| Sep 2006 | 0.00(0.0%) | 0.00(0.0%) |
| Jun 2006 | - | 0.00(0.0%) |
| Mar 2006 | - | 0.00(0.0%) |
| Dec 2005 | - | 0.00(0.0%) |
| Sep 2005 | 0.00(0.0%) | 0.00(0.0%) |
| Jun 2005 | - | 0.00(0.0%) |
| Mar 2005 | - | 0.00(0.0%) |
| Dec 2004 | - | 0.00(0.0%) |
| Sep 2004 | 0.00(0.0%) | 0.00(0.0%) |
| Jun 2004 | - | 0.00(0.0%) |
| Mar 2004 | - | 0.00(0.0%) |
| Dec 2003 | - | 0.00(0.0%) |
| Sep 2003 | 0.00(+100.0%) | 0.00(+100.0%) |
| Jun 2003 | - | -0.36(+2.7%) |
| Mar 2003 | - | -0.37(+7.5%) |
| Dec 2002 | - | -0.40(-17.6%) |
| Sep 2002 | -0.41(+4.7%) | -0.34(+20.9%) |
| Jun 2002 | - | -0.43(-10.3%) |
| Mar 2002 | - | -0.39(+4.9%) |
| Dec 2001 | - | -0.41(-17.1%) |
| Sep 2001 | -0.43(+14.0%) | -0.35(+22.2%) |
| Jun 2001 | - | -0.45(+2.2%) |
| Mar 2001 | - | -0.46(+6.1%) |
| Dec 2000 | - | -0.49(-40.0%) |
| Sep 2000 | -0.50(+12.3%) | -0.35(+27.1%) |
| Jun 2000 | - | -0.48(+5.9%) |
| Mar 2000 | - | -0.51(+5.6%) |
| Dec 1999 | - | -0.54(-42.1%) |
| Sep 1999 | -0.57(-39.0%) | -0.38(+36.7%) |
| Jun 1999 | - | -0.60(-42.9%) |
| Mar 1999 | - | -0.42 |
| Sep 1998 | -0.41(-2.5%) | - |
| Sep 1997 | -0.40 | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual debt to equity ratio?
- What is the all-time high annual debt to equity for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual debt to equity year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly debt to equity ratio?
- What is the all-time high quarterly debt to equity for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly debt to equity year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual debt to equity ratio?
The current annual debt to equity of ARWR is 1.57
What is the all-time high annual debt to equity for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual debt to equity ratio is 4.59
What is Arrowhead Pharmaceuticals, Inc. annual debt to equity year-on-year change?
Over the past year, ARWR annual debt to equity ratio has changed by -3.02 (-65.80%)
What is Arrowhead Pharmaceuticals, Inc. quarterly debt to equity ratio?
The current quarterly debt to equity of ARWR is 1.57
What is the all-time high quarterly debt to equity for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly debt to equity ratio is 16.58
What is Arrowhead Pharmaceuticals, Inc. quarterly debt to equity year-on-year change?
Over the past year, ARWR quarterly debt to equity ratio has changed by -3.02 (-65.80%)